Cargando…
Graves’ Thyrotoxicosis Following SARS-CoV-2 Infection
OBJECTIVE: Graves’ disease is an autoimmune thyroid disease that is thought to develop following environmental exposure in patients with genetic predisposition. Our objective is to present the first report of Graves’ disease onset immediately following recovery from mild coronavirus disease 2019 (CO...
Autores principales: | Harris, Asaf, Al Mushref, Mazen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association of Clinical Endocrinology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834282/ https://www.ncbi.nlm.nih.gov/pubmed/33521256 http://dx.doi.org/10.1016/j.aace.2020.12.005 |
Ejemplares similares
-
Two Cases of Severe Autoimmune Thyrotoxicosis Following SARS-CoV-2 Infection
por: Edwards, Khary, et al.
Publicado: (2021) -
Thyrotoxicosis occurrence in SARS-CoV-2 infection: A case report
por: Pranasakti, Maria Erika, et al.
Publicado: (2022) -
Lithium Monotherapy in Graves Thyrotoxicosis
por: Larkworthy, James, et al.
Publicado: (2023) -
Thyrotoxicosis in patients with a history of Graves’ disease after SARS-CoV-2 vaccination (adenovirus vector vaccine): Two case reports
por: Yan, Bo-Chang, et al.
Publicado: (2023) -
Lithium as an Alternative Option in Graves Thyrotoxicosis
por: Prakash, Ishita, et al.
Publicado: (2015)